Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Marble

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Drug Intelligence & Clinical Pharmacy|April 1, 1986
Norfloxacin: a quinoline antibioticD A Marble, J A Bosso
Drug Intelligence & Clinical Pharmacy|November 1, 1988
Compatibility and stability of cefazolin sodium, clindamycin phosphate, and gentamicin sulfate in two intravenous solutionsA S Zbrozek, D A Marble, J A Bosso
Drug Intelligence & Clinical Pharmacy|December 1, 1986
Compatibility of clindamycin phosphate with amikacin sulfate at room temperature and with gentamicin sulfate and tobramycin sulfate under frozen conditionsD A Marble, J A Bosso, R J Townsend
American Journal of Hospital Pharmacy|July 1, 1986
Stability of clindamycin phosphate with aztreonam, ceftazidime sodium, ceftriaxone sodium, or piperacillin sodium in two intravenous solutionsD A Marble, J A Bosso, R J Townsend
Drug Intelligence & Clinical Pharmacy|January 1, 1988
Compatibility of clindamycin phosphate with aztreonam in polypropylene syringes and with cefoperazone sodium, cefonicid sodium, and cefuroxime sodium in partial-fill glass bottlesD A Marble, J A Bosso, R J Townsend
Drug Intelligence & Clinical Pharmacy|October 1, 1987
Compatibility and stability of clindamycin phosphate-aminoglycoside combinations within polypropylene syringesA S Zbrozek, D A Marble, J A Bosso, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1988
Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysisD P Reitberg, D A Marble, R W Schultz, et al.
Archives of Pathology & Laboratory Medicine|May 1, 1988
In vitro inactivation of aminoglycosides by cephalosporin antibioticsD N Wright, D A Marble, B Saxon, et al.
Annals of Surgery|January 1, 1985
Clinical risk factors for prolonged PT/PTT in abdominal sepsis patients treated with moxalactam or tobramycin plus clindamycinJ G Baxter, D A Marble, L R Whitfield, et al.
The Journal of Rheumatology|February 1, 1995
Immunologic assessment during treatment of rheumatoid arthritis with anti-CD5 immunoconjugateG W Cannon, D A Marble, M M Griffiths, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Drug Intelligence & Clinical Pharmacy|April 1, 1986
Norfloxacin: a quinoline antibioticD A Marble, J A Bosso
Drug Intelligence & Clinical Pharmacy|November 1, 1988
Compatibility and stability of cefazolin sodium, clindamycin phosphate, and gentamicin sulfate in two intravenous solutionsA S Zbrozek, D A Marble, J A Bosso
Drug Intelligence & Clinical Pharmacy|December 1, 1986
Compatibility of clindamycin phosphate with amikacin sulfate at room temperature and with gentamicin sulfate and tobramycin sulfate under frozen conditionsD A Marble, J A Bosso, R J Townsend
American Journal of Hospital Pharmacy|July 1, 1986
Stability of clindamycin phosphate with aztreonam, ceftazidime sodium, ceftriaxone sodium, or piperacillin sodium in two intravenous solutionsD A Marble, J A Bosso, R J Townsend
Drug Intelligence & Clinical Pharmacy|January 1, 1988
Compatibility of clindamycin phosphate with aztreonam in polypropylene syringes and with cefoperazone sodium, cefonicid sodium, and cefuroxime sodium in partial-fill glass bottlesD A Marble, J A Bosso, R J Townsend
Drug Intelligence & Clinical Pharmacy|October 1, 1987
Compatibility and stability of clindamycin phosphate-aminoglycoside combinations within polypropylene syringesA S Zbrozek, D A Marble, J A Bosso, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1988
Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysisD P Reitberg, D A Marble, R W Schultz, et al.
Archives of Pathology & Laboratory Medicine|May 1, 1988
In vitro inactivation of aminoglycosides by cephalosporin antibioticsD N Wright, D A Marble, B Saxon, et al.
Annals of Surgery|January 1, 1985
Clinical risk factors for prolonged PT/PTT in abdominal sepsis patients treated with moxalactam or tobramycin plus clindamycinJ G Baxter, D A Marble, L R Whitfield, et al.
The Journal of Rheumatology|February 1, 1995
Immunologic assessment during treatment of rheumatoid arthritis with anti-CD5 immunoconjugateG W Cannon, D A Marble, M M Griffiths, et al.
Pageof 1